Meeting
2016 ASCO Annual Meeting
Glucocorticoid receptor expression and survival in ovarian cancer.
Authors
Jennifer Taylor Veneris
Section of Hematology-Oncology, University of Chicago Medical Center, Chicago, IL
Jennifer Taylor Veneris , Kathleen M. Darcy , Paulette Mhawech-Fauceglia , Suzanne D. Conzen , Gini F. Fleming
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gynecologic Cancer
Track
Gynecologic Cancer
Sub Track
Ovarian Cancer
Citation
J Clin Oncol 34, 2016 (suppl; abstr 5545)
DOI
10.1200/JCO.2016.34.15_suppl.5545
Abstract #
5545
Poster Bd #
368
Abstract Disclosures
Similar Posters
Poster
2017 ASCO Annual Meeting
TRUST: Trial of radical upfront surgical therapy in advanced ovarian cancer (ENGOT ov33 / AGO‐OVAR OP7).
First Author: Sven Mahner
Poster
2021 ASCO Annual Meeting
Does aggressive surgery only benefit patients with less advanced ovarian cancer?
First Author: Shinichi Tate
Poster
2019 ASCO Annual Meeting
Delays from neoadjuvant chemotherapy to interval debulking surgery and survival in ovarian cancer.
First Author: Ying L Liu
First Author: Larissa Meyer